We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
726
Regeneron Pharmaceuticals
REGN
$80.8B
$389K 0.01%
742
-233
-24% -$130K
K
727
DELISTED
Kellanova
K
$387K 0.01%
4,863
-657
-12% -$53.7K
ALLE icon
728
Allegion
ALLE
$14.4B
$387K 0.01%
2,682
-64
-2% -$8.75K
APAM icon
729
Artisan Partners
APAM
$3.02B
$386K 0.01%
8,711
-32
-0.4% -$1.28K
VTEB icon
730
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
$385K 0.01%
7,856
-24,836
-76% -$1.21M
NRG icon
731
NRG Energy
NRG
$24.8B
$385K 0.01%
2,395
+33
+1% +$4.35K
BTI icon
732
British American Tobacco
BTI
$128B
$382K 0.01%
8,061
-327
-4% -$14.5K
FOUR icon
733
Shift4
FOUR
$3.26B
$380K 0.01%
3,835
+318
+9% +$27.7K
SRAD icon
734
Sportradar
SRAD
$3.85B
$377K 0.01%
13,425
+4,040
+43% +$95.9K
LYB icon
735
LyondellBasell Industries
LYB
$19.2B
$377K 0.01%
6,509
+601
+10% +$35K
VXF icon
736
Vanguard Extended Market ETF
VXF
$31.9B
$376K 0.01%
1,953
-80
-4% -$14.2K
TAK icon
737
Takeda Pharmaceutical
TAK
$55.7B
$376K 0.01%
24,338
+4,485
+23% +$66.3K
VNQI icon
738
Vanguard Global ex-US Real Estate ETF
VNQI
$3.57B
$375K 0.01%
8,133
-32
-0.4% -$1.38K
BLV icon
739
Vanguard Long-Term Bond ETF
BLV
$5.74B
$374K 0.01%
5,385
+4,747
+744% +$324K
SYY icon
740
Sysco
SYY
$40.3B
$374K 0.01%
4,940
+371
+8% +$26.9K
DFAU icon
741
Dimensional US Core Equity Market ETF
DFAU
$12.8B
$374K 0.01%
8,831
SKM icon
742
SK Telecom
SKM
$13.2B
$373K 0.01%
15,955
+13,465
+541% +$290K
WPM icon
743
Wheaton Precious Metals
WPM
$60.9B
$372K 0.01%
4,146
+76
+2% +$6.4K
VLTO icon
744
Veralto
VLTO
$24B
$372K 0.01%
3,684
+24
+0.7% +$2.31K
IWX icon
745
iShares Russell Top 200 Value ETF
IWX
$4.03B
$370K 0.01%
4,398
SDVY icon
746
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.8B
$370K 0.01%
10,492
+1,420
+16% +$47.6K
AMLP icon
747
Alerian MLP ETF
AMLP
$13.1B
$369K 0.01%
7,558
+572
+8% +$27.7K
DFAS icon
748
Dimensional US Small Cap ETF
DFAS
$15.8B
$369K 0.01%
5,795
-836
-13% -$50.1K
IMCV icon
749
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$369K 0.01%
4,850
+1,300
+37% +$94.6K
ESLT icon
750
Elbit Systems
ESLT
$40.3B
$364K 0.01%
809
-3
-0.4% -$1.22K

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.